Search

Search Constraints

You searched for: Author/Creator Halank, Michael

Search Results

1. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study. (July 2017)

3. Mutually reinforcing effects of genetic variants and interferon-β 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients. (September 2019)

4. Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. Issue 3 (March 2019)

7. Profiles and treatment patterns of patients with pulmonary arterial hypertension on monotherapy at experienced centres. (15th June 2022)

8. Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients. Issue 5 (8th November 2018)

9. An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension. (20th January 2022)

10. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis. Issue 10 (October 2022)